Evidence map›Paper›PMID 31683806›Full record

ArticleCancers2019

Next-Generation Multimodality of Nanomedicine Therapy: Size and Structure Dependence of Folic Acid Conjugated Copolymers Actively Target Cancer Cells in Disabling Cell Division and Inducing Apoptosis.

Manpreet Sambi, Alexandria DeCarlo, Cecile Malardier-Jugroot, Myron R Szewczuk

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Carborane-Containing Folic AcidInternational journal of molecular sciences · 2022
    Article
  3. Article
  4. Functionalized Poly(Gels (Basel, Switzerland) · 2021
    Article
  5. Review
  6. Cancer Nanomedicine.Cancers · 2020
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Manpreet SambiDepartment of Biomedical and Molecular Sciences, Queen's University, Kingston, ON K7L 3N6, Canada. 13ms84@queensu.ca.
Alexandria DeCarloDepartment of Biomedical and Molecular Sciences, Queen's University, Kingston, ON K7L 3N6, Canada. 14ald4@queensu.ca.
Cecile Malardier-JugrootDepartment of Chemistry and Chemical Engineering, Royal Military College of Canada, Kingston, ON K7K 7B4, Canada. Cecile.Malardier-Jugroot@rmc.ca.
Myron R SzewczukDepartment of Biomedical and Molecular Sciences, Queen's University, Kingston, ON K7L 3N6, Canada. szewczuk@queensu.ca.
Queen's University · CARoyal Military College of Canada · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanomedicine as a multimodality treatment of cancer utilizes the advantages of nanodelivery systems of drugs. They are superior to the clinical administration of different therapeutic agents in several aspects, including simultaneous delivery of drugs to the active site, precise ratio control of the loading drugs and overcoming multidrug resistance. The role of nanopolymer size and structural shape on the internalization process and subsequent intracellular toxicity is limited. Here, the size and shape dependent mechanism of a functionalized copolymer was investigated using folic acid (FA) covalently bonded to the copolymer poly (styrene-

Indexed as

active targetingdrug deliveryFA-DABA-SMAfolic receptor alphaintracellular disruptionnanomedicineoncogenic proteinsself-assembly

Identifiers

PMID31683806
PMCPMC6896001
OpenAlexW2986245988

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.